Literature DB >> 14871518

HPV prevalence among partners of women with cervical intraepithelial neoplasia.

C Rosenblatt1, A M Lucon, E A G Pereyra, J A Pinotti, S Arap, C A Ruiz.   

Abstract

OBJECTIVES: The objective of this study was to find HPV DNA incidence in women with CIN and normal women and in their respective partners, as well as the relation between the virus groups found in women with CIN or normal women and in their respective partners.
METHODS: Partners of 30 women with CIN at several grades and of 60 normal women were prospectively assessed. In men, HPV search was performed by collecting samples through penile scraping for Hybrid Capture, followed by peniscopic evaluation and biopsy of acetowhite lesions.
RESULTS: The presence of HPV DNA in male partners does not necessarily implicate the presence of HPV or even CIN in their female partners.
CONCLUSIONS: If these results are confirmed by other authors, obtaining a peniscopy, a penile biopsy, and a HPV DNA search in partners that present with no clinical lesions, but in couples with women having CIN, would not be warranted.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871518     DOI: 10.1016/j.ijgo.2003.08.008

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Male circumcision is associated with a lower prevalence of human papillomavirus-associated penile lesions among Kenyan men.

Authors:  Danielle M Backes; Maaike C G Bleeker; Chris J L M Meijer; Michael G Hudgens; Kawango Agot; Robert C Bailey; J O Ndinya-Achola; Juma Hayombe; Cornelis J A Hogewoning; Stephen Moses; Peter J F Snijders; Jennifer S Smith
Journal:  Int J Cancer       Date:  2011-08-02       Impact factor: 7.396

2.  Human papillomavirus concordance in heterosexual couples.

Authors:  Lea E Widdice; David J Breland; Janet Jonte; Sepideh Farhat; Yifei Ma; Anthony C Leonard; Anna-Barbara Moscicki
Journal:  J Adolesc Health       Date:  2010-03-24       Impact factor: 5.012

3.  Prevalence, concordance and determinants of human papillomavirus infection among heterosexual partners in a rural region in central Mexico.

Authors:  Rocio Parada; Rosalba Morales; Anna R Giuliano; Aurelio Cruz; Xavier Castellsagué; Eduardo Lazcano-Ponce
Journal:  BMC Infect Dis       Date:  2010-07-28       Impact factor: 3.090

4.  Prevalence of DNA-HPV in male sexual partners of HPV-infected women and concordance of viral types in infected couples.

Authors:  Maria Gabrielle de Lima Rocha; Fabio Lopes Faria; Leonor Gonçalves; Maria do Carmo M Souza; Paula Ávila Fernandes; Ana Paula Fernandes
Journal:  PLoS One       Date:  2012-07-17       Impact factor: 3.240

5.  Human papilloma virus (HPV) genotypes concordance between Iranian couples referrals.

Authors:  Mehrdad Davarmanesh; Mehrouz Dezfulian; Mohammad Javad Gharavi; Sarang Younesi; Pourandokht Saadati; Mohammad Mehdi Taheri Amin; Seyed Mohammad Jazayeri
Journal:  Infect Agent Cancer       Date:  2019-09-09       Impact factor: 2.965

6.  A six-year study of the clinical presentation of cervical cancer and the management challenges encountered at a state teaching hospital in southeast Nigeria.

Authors:  Justus N Eze; Esther N Emeka-Irem; Felix O Edegbe
Journal:  Clin Med Insights Oncol       Date:  2013-06-27

7.  Human papillomavirus infection among sexual partners attending a Sexually Transmitted Disease Clinic in Rio de Janeiro, Brazil.

Authors:  L A Afonso; W M Rocha; F N Carestiato; E A Dobao; L F Pesca; M R L Passos; S M B Cavalcanti
Journal:  Braz J Med Biol Res       Date:  2013-05-24       Impact factor: 2.590

8.  Prevalence of human papillomavirus (HPV) in Brazil: A systematic review and meta-analysis.

Authors:  Verônica Colpani; Frederico Soares Falcetta; Augusto Bacelo Bidinotto; Natália Luiza Kops; Maicon Falavigna; Luciano Serpa Hammes; Adele Schwartz Benzaken; Ana Goretti Kalume Maranhão; Carla Magda Allan S Domingues; Eliana Márcia Wendland
Journal:  PLoS One       Date:  2020-02-21       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.